In recent years, the study of dynamic modifications in biomacromolecules has revolutionized our understanding of cellular regulation and disease pathology. These chemical modifications—occurring on fundamental life molecules such as nucleic acids and proteins—are not static but highly dynamic, involving changes in type, intensity, distribution, and reversibility across time and space within cells. Recognizing the importance of these molecular switches, the National Natural Science Foundation of China (NSFC) launched in 2017 a groundbreaking Major Research Plan titled “Dynamic Modifications and Chemical Interventions of Biomacromolecules,” aiming to explore these complex modifications through an interdisciplinary lens. The initiative has since catalyzed remarkable advances in chemical biology, life sciences, and medicine, setting a new paradigm for understanding biological regulation and therapeutic innovation.
Dynamic biomacromolecular modifications involve diverse chemical changes including methylation, acetylation, phosphorylation, ubiquitination, and emerging modifications such as RNA m6A methylation. These transformations regulate gene expression, signal transduction, metabolic fluxes, and protein function with exquisite precision. The temporal and spatial flexibility of these modifications underpins critical physiological processes and also contributes to disease phenotypes when dysregulated. As our toolbox for probing these dynamic events expands, so does our capacity to decode complex biological networks and identify novel drug targets relevant to diseases like cancer, diabetes, and neurodegenerative disorders.
Despite their significance, traditional research models have struggled to capture the transient and reversible nature of these modifications. Many of the enzymes responsible for “writing,” “erasing,” and “reading” modifications had only recently been discovered, highlighting the complexity embedded in cellular regulation. To overcome these challenges, the Chinese scientific community, spearheaded by the NSFC, promoted an interdisciplinary approach combining chemistry, biology, medicine, materials science, mathematics, and information science. This confluence aimed to develop innovative chemical tools capable of precise labeling, detection, and functional intervention of dynamic biomacromolecular modifications.
Since its inception, the Major Research Plan has achieved substantial progress in both fundamental biology and chemical methodology. Researchers have engineered highly selective chemical probes that can tag modifications with temporal resolution, enabling real-time tracking of modification dynamics in living cells and tissues. Advanced mass spectrometry techniques coupled with bioinformatics algorithms have facilitated the identification of previously unknown modification sites and patterns, revealing new layers of epigenetic and post-translational regulation. These technologies have empowered scientists to dissect the interplay between modification enzymes and their substrates within intricate cellular contexts.
One of the hallmark achievements highlighted in a recent systematic review published in CCS Chemistry is the unveiling of molecular mechanisms by which dynamic modifications regulate core life processes such as gene expression and cellular metabolism. For instance, studies have revealed how RNA modifications modulate mRNA stability and translation efficiency, affecting developmental programs and stress responses. Similarly, dynamic histone acetylation and methylation patterns orchestrate chromatin remodeling and transcriptional outcomes during differentiation and disease progression. These insights underscore the vital role of biomacromolecular modifications as molecular switches integrating diverse cellular signals.
The review also illuminates how precision chemical interventions are emerging as powerful strategies to manipulate dynamic modifications for therapeutic ends. By designing small-molecule inhibitors or activators targeting modification enzymes with high selectivity, scientists are altering aberrant modification landscapes associated with diseases. This chemical approach transcends conventional genetic manipulation and offers new avenues to modulate protein and nucleic acid functions in situ. Particularly promising are lead compounds that have advanced to preclinical studies exhibiting efficacy against cancer and metabolic disorders, reflecting the translational potential of this research.
Beyond therapeutic implications, the integration of chemical biology with mathematics and information science has fostered the development of predictive models and computational tools that map dynamic modification networks on a systems level. These models allow researchers to simulate cellular responses to environmental and pathological stimuli, providing a holistic understanding that bridges molecular detail and organismal physiology. This systems chemistry approach promises to accelerate biomarker discovery and precision medicine by anticipating modification-driven cellular changes.
The functioning of dynamic modifications does not occur in isolation but within sophisticated regulatory networks involving multiple enzymes and interacting partners. Recent research supported by the Major Research Plan has identified novel modifying and demodifying enzymes, expanding the catalog of molecular players that shape the epigenetic and post-translational landscapes. Indispensable to this progress has been the advancement in high-throughput screening methods and chemical genetics approaches, enabling the systematic probing of enzyme activities and substrate selectivity.
Importantly, this initiative has fostered robust interdisciplinary collaboration across institutions in China, uniting chemists, biologists, clinicians, and computational scientists. This collaborative framework has been critical to tackling complex challenges inherent in studying dynamic biomacromolecular modifications. The fusion of expertise across disciplines has cultivated innovative methodologies and translated fundamental insights into potential clinical applications, exemplifying the synergy between fundamental research and applied science.
As the Major Research Plan approaches its conclusion in 2025, the collective achievements reflect China’s growing leadership in chemical biology and biomedical research. The review article published in CCS Chemistry not only consolidates the breakthroughs attained but also casts a forward-looking perspective on core challenges that remain. Among these challenges are the need for even higher resolution detection technologies, achieving selective modulation of modifications in vivo without off-target effects, and integrating multi-omics data to fully comprehend modification crosstalk.
Looking ahead, the field is poised to harness emerging technologies such as artificial intelligence, single-molecule imaging, and synthetic biology to unravel the complexities of biomacromolecular modifications at unprecedented scale and precision. The continuous discovery of new modification types and their dynamic interplay will undoubtedly shape future strategies for disease diagnosis, prognosis, and personalized treatment interventions.
This remarkable journey underscores how dynamic chemical modifications transcend traditional molecular biology, weaving chemistry deeply into the fabric of life sciences and medicine. The “chemical weapons” developed through this Major Research Plan not only offer powerful means to decode the language of biological modifications but also hold the promise to revolutionize therapeutic approaches globally. The synthesis of chemistry, biology, and medicine evident in this program sets an inspiring example of how interdisciplinary science can drive transformative innovation.
In parallel, the Chinese Chemical Society’s flagship journal, CCS Chemistry, has served as a prominent platform to disseminate cutting-edge research in this domain. As a fully open-access publication, it fosters international collaboration and knowledge-sharing in chemical sciences, amplifying the global impact of Chinese scientific contributions. By nurturing a vibrant research community and maintaining rigorous scholarly standards, CCS Chemistry continues to be instrumental in advancing frontier fields such as dynamic biomacromolecular modifications.
In essence, the Major Research Plan “Dynamic Modifications and Chemical Interventions of Biomacromolecules” represents a landmark scientific endeavor integrating chemical biology with life sciences and medicine. It propels our understanding of life’s fundamental molecular language and paves the way for novel diagnostic and therapeutic paradigms. As the field evolves, it is clear that the dynamic nature of biomacromolecular modifications will remain a focal point for innovation, offering exciting opportunities to decipher and ultimately manipulate the chemistry of life.
Subject of Research: Not applicable
Article Title: Recent Advances in Dynamic Biomacromolecular Modifications and Chemical Interventions: Perspective from a Chinese Chemical Biology Consortium
News Publication Date: 28-Aug-2025
Web References: https://www.chinesechemsoc.org/journal/ccschem
Image Credits: CCS Chemistry
